drugset / Trial / NCT06206564
Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
Phase 2
Recruiting
48 enrolled
Frantz Viral Therapeutics, LLC
Anal Dysplasia Clinic MidWest · collabLaser Surgery Care · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a phase II double blind, placebo-controlled, randomized study of artesunate ointment for the treatment of HIV-negative men and women who have anal high grade squamous intraepithelial lesions (anal HSIL)
Timeline
- Start
- 2024-01-12
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artesunate | Small molecule | — | Topical |